Well, Moderna at least. But they own most of the patents. Pfizer is getting out of mRNA. They refuse to take on the risk once indemnification is removed. But ...
No one wants to talk about how badly mRNA Influenza vaccines were during their 3 year trials. No one is going to either. In fact, if you do ... banks will debank you and destroy your practice or livelihood.
Most of our data before the SARS-CoV-2 outbreak, aka COVID-19, was all from those trials for flu. They had far more side effects with no better, or worse, effiacy. Even major medical journals covered this in 2016-2017.**
Even the two (2) SARS-CoV-2 medicines are repurposed Influenza medicines that failed. The US DoD finally yanked funding of one, and BARDA's chief lambasted it, all whlie Fauci was still pimping it.
The public peer review is non-existant. It's protected by patents and even US federal agencies are required to sign NDAs and other agreements.
**Related Stat Articles on mRNA influenza devleopment and trials (2016-2017)
Moderna's caustic work environment has driven away top talent. There are signs the secretive startup has hit roadblocks with its most ambitious projects.
www.statnews.com
Moderna Therapeutics, the most highly valued private company in biotech, has run into troubling safety problems with its most ambitious therapy, STAT found.
www.statnews.com